Prediction of outcome of early ER+ breast cancer is improved using a biomarker panel, which includes Ki-67 and p53

BACKGROUND: The aim of this study is to determine whether immunohistochemical (IHC) assessment of Ki67 and p53 improves prognostication of oestrogen receptor-positive (ER+) breast cancer after breast-conserving therapy (BCT). In all, 498 patients with invasive breast cancer from a randomised trial o...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Millar, E K A, Graham, P H, McNeil, C M, Browne, L, O'Toole, S A, Boulghourjian, A, Kearsley, J H, Papadatos, G, Delaney, G, Fox, C, Nasser, E, Capp, A, Sutherland, R L
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2011
Assuntos:
Molecular Diagnostics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3142808/
https://ncbi.nlm.nih.gov/pubmed/21712826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.228
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares